Publicacións en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (17)

2023

  1. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Characterization of hereditary transthyretin cardiac amyloidosis in Spain

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 488-495

2021

  1. Spontaneous coronary artery dissection in Spain: clinical and angiographic characteristics, management, and in-hospital events

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 15-23

2020

  1. Adherence to prophylaxis in adult patients with severe haemophilia A

    Haemophilia, Vol. 26, Núm. 5, pp. 800-808

  2. Real-life effect of a microcrystalline tyrosine adjuvanted mite immunotherapy in patients with allergic rhinitis

    Immunotherapy, Vol. 12, Núm. 1, pp. 53-62

  3. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

  2. SEOM clinical guidelines to primary prevention of cancer (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 106-113

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2016

  1. Penetrancia familiar en la parada cardíaca en ausencia de cardiopatía aparente: Observaciones del estudio FIVI-Gen

    Cardiocore, Vol. 51, Núm. 1, pp. 30-36

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

  2. Maternal and Perinatal Outcomes After Bariatric Surgery: a Spanish Multicenter Study

    Obesity Surgery, Vol. 25, Núm. 3, pp. 436-442

2005

  1. Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: Final results of a phase II trial

    Clinical Breast Cancer, Vol. 6, Núm. 5, pp. 433-438

  2. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2001

  1. Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C

    Journal of Medical Virology, Vol. 64, Núm. 4, pp. 460-465

1997

  1. Multicenter randomized, controlled study of intramuscular administration of interferon-β for the treatment of chronic hepatitis C

    Journal of Interferon and Cytokine Research, Vol. 17, Núm. 1, pp. 27-30

  2. Tolerance and efficacy of subcutaneous interferon-β administered for treatment of chronic hepatitis C

    Journal of Interferon and Cytokine Research, Vol. 17, Núm. 2, pp. 65-67